MENU
+Compare
RXST
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$9.58
Change
-$0.43 (-4.30%)
Capitalization
411.29M

RXST RxSight Forecast, Technical & Fundamental Analysis

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery... Show more

RXST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RXST with price predictions
Nov 12, 2025

Aroon Indicator for RXST shows an upward move is likely

RXST's Aroon Indicator triggered a bullish signal on November 12, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 187 similar instances where the Aroon Indicator showed a similar pattern. In of the 187 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2025. You may want to consider a long position or call options on RXST as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RXST just turned positive on October 20, 2025. Looking at past instances where RXST's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

RXST moved above its 50-day moving average on November 07, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RXST crossed bullishly above the 50-day moving average on November 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RXST advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RXST moved out of overbought territory on November 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RXST broke above its upper Bollinger Band on November 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RXST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.490) is normal, around the industry mean (63.534). P/E Ratio (0.000) is within average values for comparable stocks, (37.086). RXST's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). RXST has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (2.862) is also within normal values, averaging (79.919).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
RXST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RXST is expected to report earnings to rise 811.00% to -36 cents per share on March 10

RxSight RXST Stock Earnings Reports
Q4'25
Est.
$-0.36
Q3'25
Beat
by $0.34
Q2'25
Missed
by $0.10
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.20
The last earnings report on November 05 showed earnings per share of -3 cents, beating the estimate of -37 cents. With 278.64K shares outstanding, the current market capitalization sits at 411.29M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
100 Columbia
Phone
+1 949 521-7830
Employees
374
Web
https://www.rxsight.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTNSX14.530.08
+0.55%
Russell Inv Tax-Managed Intl Eq S
RPMYX12.390.05
+0.41%
Reinhart International PMV Advisor
ASQCX15.470.02
+0.13%
American Century Small Company C
EKJCX3.30-0.01
-0.30%
Allspring Premier Large Co Gr C
ESCWX11.26-0.04
-0.35%
Embark Small Cap Equity Institutional

RXST and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with SONVY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then SONVY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
-2.15%
SONVY - RXST
36%
Loosely correlated
+1.75%
TRUMY - RXST
34%
Loosely correlated
-6.35%
INMD - RXST
32%
Poorly correlated
+0.69%
KIDS - RXST
32%
Poorly correlated
-1.28%
QTRX - RXST
31%
Poorly correlated
+4.40%
More

Groups containing RXST

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
-2.15%
Medical/Nursing Services
industry (215 stocks)
32%
Poorly correlated
-2.32%
Health Services
industry (422 stocks)
-2%
Poorly correlated
-2.10%